TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05298644

COVID-19 Paediatric VLA2001-321 Study

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.
“Valneva has contacted regulators to align on potential adjustments to the previously agreed Pediatric Investigational Plan. Valneva has suspended VLA2001 pediatric development, and study VLA2001-321 will not commence.”

The sponsor’s own words in the registry.

Life of this trial

202220232024Registered2022-03-16Planned start2022-10-01 (planned)Withdrawn (as of)2022-11-08

Vital statistics

Status
Withdrawn
Phase
Phase 2, Phase 3
Sponsor
Valneva Austria GmbH
Sponsor type
Industry
Conditions
SARS-CoV-2 Infection
Interventions
VLA2001; Active Comparator
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.